home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Gaining Entry Into The Brain

 
  January, 9 2008 23:01
your information resource in human molecular genetics
 
     

Researchers have identified a protein used by aggressive immune cells seeking to breach the blood-brain barrier, reports a paper published online in Nature Immunology. Normally few immune cells enter the brains of healthy animals. However, neuroinflammatory disorders result in weakening of the blood-brain barrier, and entry of potentially dangerous immune cells into the central nervous system.

Alexandre Prat and colleagues show that the adhesion protein ALCAM acts as a 'foothold' for immune cells moving between blood-brain barrier endothelial cells. Blockade of ALCAM reduced the severity and slowed the progression of experimental autoimmune encephalomyelitis, a mouse model of human multiple sclerosis, and ALCAM worked synergistically with another adhesion molecule, ICAM1, to move immune cells across the blood-brain barrier.

Future work is needed to determine whether ALCAM blockade holds therapeutic utility in treating established human neuroinflammatory diseases.

Author contact:

Alexandre Prat (CHUM-Notre-Dame Hospital, Montreal, Canada)
E-mail: aprat@umontreal.ca

Abstract available online.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.